###begin article-title 0
###xml 72 77 <span type="species:ncbi:9606">Human</span>
PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons
###end article-title 0
###begin p 1
Conceived and designed the experiments: JD ST NW SG LM PJ JT SH MD DL AW. Performed the experiments: SG ZY AA EM GK LS IH KK AW ED. Analyzed the data: ST SG AA LS IH SH AW. Contributed reagents/materials/analysis tools: JD ST EM GK LM PJ JT SH MD DL ED. Wrote the paper: SG AW.
###end p 1
###begin p 2
paragraph sign These authors also contributed equally to this work.
###end p 2
###begin p 3
###xml 450 455 <span type="species:ncbi:9606">human</span>
###xml 468 473 <span type="species:ncbi:10090">mouse</span>
###xml 532 537 <span type="species:ncbi:9606">human</span>
###xml 650 655 <span type="species:ncbi:9606">human</span>
###xml 776 781 <span type="species:ncbi:10090">mouse</span>
###xml 865 870 <span type="species:ncbi:9606">human</span>
###xml 875 880 <span type="species:ncbi:10090">mouse</span>
###xml 947 952 <span type="species:ncbi:9606">human</span>
###xml 1013 1018 <span type="species:ncbi:9606">Human</span>
Parkinson's disease (PD) is a common age-related neurodegenerative disease and it is critical to develop models which recapitulate the pathogenic process including the effect of the ageing process. Although the pathogenesis of sporadic PD is unknown, the identification of the mendelian genetic factor PINK1 has provided new mechanistic insights. In order to investigate the role of PINK1 in Parkinson's disease, we studied PINK1 loss of function in human and primary mouse neurons. Using RNAi, we created stable PINK1 knockdown in human dopaminergic neurons differentiated from foetal ventral mesencephalon stem cells, as well as in an immortalised human neuroblastoma cell line. We sought to validate our findings in primary neurons derived from a transgenic PINK1 knockout mouse. For the first time we demonstrate an age dependent neurodegenerative phenotype in human and mouse neurons. PINK1 deficiency leads to reduced long-term viability in human neurons, which die via the mitochondrial apoptosis pathway. Human neurons lacking PINK1 demonstrate features of marked oxidative stress with widespread mitochondrial dysfunction and abnormal mitochondrial morphology. We report that PINK1 plays a neuroprotective role in the mitochondria of mammalian neurons, especially against stress such as staurosporine. In addition we provide evidence that cellular compensatory mechanisms such as mitochondrial biogenesis and upregulation of lysosomal degradation pathways occur in PINK1 deficiency. The phenotypic effects of PINK1 loss-of-function described here in mammalian neurons provides mechanistic insight into the age-related degeneration of nigral dopaminergic neurons seen in PD.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 791 794 775 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-deRijk1">[1]</xref>
###xml 1198 1201 1178 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Polymeropoulos1">[2]</xref>
###xml 1234 1237 1214 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Kitada1">[3]</xref>
###xml 1278 1281 1258 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Bonifati1">[4]</xref>
###xml 1339 1342 1319 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Valente1">[5]</xref>
###xml 1387 1390 1367 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Strauss1">[6]</xref>
###xml 1433 1436 1413 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Zimprich1">[7]</xref>
###xml 1721 1724 1701 1704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-WoodKaczmar1">[8]</xref>
###xml 348 356 <span type="species:ncbi:9606">patients</span>
Parkinson's disease (PD) is the most common neurodegenerative motor disorder in the Western world. The disease is characterised clinically by resting tremor, rigidity and slowness of movement (bradykinesia) with symptoms being partially alleviated by administration of exogenous dopamine (L-dopa). Upon neuropathological examination, the brains of patients with PD show marked loss of pigmented dopaminergic (DAergic) neurons of the substantia nigra pars compacta (SNpc), and other brain regions. In addition, surviving neurons frequently contain Lewy bodies (LBs) which are intracytoplasmic proteinaceous inclusions, predominantly composed of aggregated alpha-synuclein. PD is a progressive, incurable and age-related disease, affecting approximately1.8% individuals by the age of 65 years [1]. The majority (>85%) of PD cases are sporadic, and the underlying molecular causes unknown. Insight into the mechanisms of PD pathogenesis has come from the identification of mutations in genes associated principally with familial forms of PD. Inherited forms of PD have been linked to mutations in six different genes with seemingly diverse functions. These encode the synaptic protein alpha-synuclein [2]; an E3 ubiquitin ligase, parkin [3]; a putative antioxidant chaperone, DJ-1 [4], a mitochondrial kinase, (PTEN)-induced kinase 1 (PINK1) [5], a mitochondrial serine protease, OMI/HTRA2 [6], and leucine-rich repeat kinase 2 (LRRK2) [7]. Discovery of these genes have strongly implicated certain cellular processes in the etiology of both inherited and sporadic disease; namely protein aggregation and impairment of the ubiquitin proteasome system, mitochondrial dysfunction, oxidative stress and protein phosphorylation [8].
###end p 5
###begin p 6
###xml 229 232 229 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Langston1">[9]</xref>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Sherer1">[10]</xref>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Bogaerts1">[11]</xref>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Jenner1">[12]</xref>
###xml 982 985 982 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Valente1">[5]</xref>
###xml 987 990 987 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Strauss1">[6]</xref>
###xml 992 996 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-PlunFavreau1">[13]</xref>
###xml 1167 1171 1163 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-CanetAviles1">[14]</xref>
###xml 1172 1176 1168 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Smith1">[17]</xref>
The role of mitochondrial dysfunction in PD has been suggested since the original discovery that the complex I inhibitor 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) caused the development of PD in recreational drug users [9]. Other complex I inhibitors including rotenone and paraquat have similarly been found to cause PD-like symptoms in rodent models [10]. Inhibition of the mitochondrial respiratory chain is known to increase the generation of free radicals leading to cellular oxidative stress within cells [11]. Concordantly, evidence of impaired complex I activity has been reported in post-mortem PD brain tissue with an increase in markers of oxidative stress [12]. However the most convincing evidence to date has been the characterisation of genes mutated in familial PD with putative functional roles within mitochondria. Both PINK1 and Omi/HtrA2 have predicted mitochondrial targeting sequences and appear to exhibit protective functions within this organelle [5], [6], [13]. Parkin, DJ-1, alpha-synuclein and LRRK2 have also been shown to associate with the mitochondrion or impact upon its function, but the mechanisms involved remain unclear [14]-[17].
###end p 6
###begin p 7
###xml 137 140 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Valente1">[5]</xref>
###xml 275 283 275 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Beilina1">[18]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Sim1">[20]</xref>
###xml 454 457 454 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Valente1">[5]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Silvestri1">[19]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Gandhi1">[21]</xref>
###xml 594 598 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Gandhi1">[21]</xref>
###xml 600 604 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Muqit1">[22]</xref>
###xml 713 717 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Unoki1">[23]</xref>
###xml 845 849 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Gandhi1">[21]</xref>
###xml 851 855 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Taymans1">[24]</xref>
###xml 646 651 <span type="species:ncbi:9606">human</span>
PINK1 is a highly conserved 581 amino acid protein with a catalytic serine/threonine kinase domain with close sequence homology to CAMK1 [5]. Several studies have demonstrated that recombinant PINK1 can undergo autophosphorylation as well as phosphorylate generic substrates in vitro[18]-[20]. It has a predicted N-terminal mitochondrial targeting motif and a significant proportion has been localised to both the inner and outer mitochondrial membranes [5], [19], [21]. Full length PINK1 pre-protein (approximately63 kDa) can also be cleaved to a 'mature' form (54 kDa) by an unknown protease [21], [22]. PINK1 mRNA is ubiquitously expressed in human tissues, with highest expression in heart, muscle and testes [23]. It is uniformly expressed in mammalian brain, with highest expression levels found within the cell bodies of neurons and glia [21], [24].
###end p 7
###begin p 8
###xml 200 203 200 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Valente1">[5]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Gandhi1">[21]</xref>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Ibanez1">[25]</xref>
###xml 588 592 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Valente2">[27]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Ibanez1">[25]</xref>
###xml 911 915 911 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Sim1">[20]</xref>
###xml 976 984 976 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1044 1048 1044 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Beilina1">[18]</xref>
###xml 1050 1054 1050 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Sim1">[20]</xref>
###xml 1242 1246 1242 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Grunewald1">[28]</xref>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
###xml 559 566 <span type="species:ncbi:9606">patient</span>
###xml 1233 1241 <span type="species:ncbi:9606">patients</span>
Homozygous and compound heterozygous mutations in the PINK1 gene locus are known to cause PARK6 familial Parkinsonism, which is indistinguishable from idiopathic PD apart from an earlier age of onset [5]. To date there are no neuropathological data from any individual affected with a homozygous mutation in the PINK1 gene. However, brains of patients with PINK1 heterozygote mutations display the typical pathological hallmarks of idiopathic PD [21]. The prevalence of PINK1 mutations in autosomal recessive early onset PD range from 0-15%, depending on the patient series analysed [25]-[27]. This suggests that PINK1 is the second most common causative gene in early onset PD after parkin [25]. The vast majority of pathogenic mutations in PINK1 gene are located within the kinase domain and include nonsense, missense and deletion mutations which are predicted to either reduce or obliterate kinase activity [20]. Accordingly, reduced kinase activity has been demonstrated in vitro for the pathogenic mutations G309D, L437P, G386A and G409V [18], [20]. The most common mutation, a C1366T transition, reportedly triggers nonsense-mediated mRNA decay, resulting in a 80-90% reduction in transcript levels in tissues from homozygous patients [28]. Taken together, these findings suggest that PARK6 parkinsonism results from a loss-of-function of the PINK1 protein.
###end p 8
###begin p 9
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Kitada2">[29]</xref>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Zhou1">[30]</xref>
###xml 345 355 345 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 452 456 452 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Clark1">[31]</xref>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Yang1">[34]</xref>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Clark1">[31]</xref>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Park1">[32]</xref>
###xml 578 582 578 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Yang1">[34]</xref>
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Park1">[32]</xref>
###xml 669 673 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Yang1">[34]</xref>
###xml 822 826 810 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Park1">[32]</xref>
###xml 827 831 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Yang1">[34]</xref>
###xml 1006 1010 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Park1">[32]</xref>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 299 304 <span type="species:ncbi:10090">mouse</span>
###xml 345 355 <span type="species:ncbi:7227">Drosophila</span>
Valid animal models of PINK1 parkinsonism should recapitulate the motor symptoms seen in patients as well as the underlying nigrostriatal deficiencies and neuropathological findings. However, no motor impairments or other non-motor parkinsonian symptoms have been reported in PINK1 loss-of-function mouse models to date [29], [30]. In contrast, Drosophila models of PINK1 deficiency have given us closer insights into the molecular mechanisms involved [31]-[34]. Motor deficits include abnormal wing posture, rigidity, flight impairment and reduced climbing ability [31], [32], [34]. Moreover, some of these motor phenotypes were found to be progressive with age [32], [34] and showed partial but significant decreases (approximately10%) in the numbers of dopaminergic neurons in certain key clusters within the fly brain [32]-[34]. Ultrastructurally, muscle fibres contained vacuolated, swollen and dysmorphic mitochondria, with disorganised christae which was also seen in surviving dopaminergic neurons [32]. Both ATP production and resistance to oxidative stressors was compromised in PINK1 deficient flies. Although fly models of PINK1 loss-of-function have recapitulated mitochondrial dysfunction and age-related neuronal death, the actual mechanisms remain unclear.
###end p 9
###begin title 10
Cellular pathogenesis of PINK1 loss of function in PD
###end title 10
###begin p 11
###xml 96 104 96 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 275 278 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Valente1">[5]</xref>
###xml 475 478 475 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Valente1">[5]</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Petit1">[35]</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Wang2">[36]</xref>
###xml 644 648 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Deng1">[37]</xref>
###xml 650 654 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Haque1">[38]</xref>
###xml 1140 1144 1140 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-PlunFavreau1">[13]</xref>
###xml 894 898 <span type="species:ncbi:10090">mice</span>
The molecular mechanism by which PINK1 operates in the mitochondria is undefined, but the first in vitro cellular studies of PINK1 loss-of-function implicated a role for the kinase in maintenance of mitochondrial membrane potential and prevention of stress-induced apoptosis [5]. Over-expression of wild-type (but not pathogenic variants) in tumour cell lines was subsequently shown to prevent release of cytochrome c from mitochondria and caspase-3 activation during stress [5], [35], [36]. In contrast, depletion of PINK1 from cells using transient RNA interference (RNAi) was shown to increase the rate of basal and stress-induced apoptosis [37], [38]. A novel pathway for PINK1 has recently been proposed following the identification of the serine protease HtrA2/Omi as a PINK1 interactor. Mutations in HtrA2 are a susceptibility factor for PD (PARK13 locus) and loss of function models in mice display a neurodegenerative phenotype resembling parkinsonism. Phosphorylation of HtrA2 at Ser142 is dependent on PINK1 and the phosphorylated form demonstrates increased protease activity and enhanced protective effect in cells upon stress [13].
###end p 11
###begin p 12
###xml 98 106 98 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Donato1">[39]</xref>
###xml 1394 1402 1394 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 231 236 <span type="species:ncbi:9606">human</span>
###xml 265 270 <span type="species:ncbi:9606">human</span>
###xml 374 379 <span type="species:ncbi:9606">human</span>
###xml 635 640 <span type="species:ncbi:10090">mouse</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 683 688 <span type="species:ncbi:9606">human</span>
###xml 861 866 <span type="species:ncbi:9606">human</span>
###xml 1292 1297 <span type="species:ncbi:9606">human</span>
To date the majority of studies of PINK1 function come from non-mammalian models, or non-neuronal in vitro cell models cultured over relatively short periods of time. Whilst yielding important insights they do not recapitulate the human disease, that is, in ageing human dopaminergic neurons. To address this issue, we created a unique model of PINK1 loss-of-function, in a human neural stem cell (NSC) line that is able to differentiate into functional dopaminergic neurons [39]. This novel cellular system recapitulates the key features of PD namely dysfunction and death in ageing midbrain neurons. In addition, we utilised primary mouse neurons taken from mice and a widely used human dopaminergic neuroblastoma cell line (SHSY5Y), which allowed cross-validation in three complementary cellular systems. We report the spatio-temporal expression of PINK1 in human dopaminergic neurons, and the effects of PINK1 deficiency including chronic mitochondrial dysfunction, an increase in oxidative stress, and lysosomal pathology. These phenotypic effects may all contribute to the marked decrease in long term viability of PINK1 deficient neurons and enhanced basal and stress-induced caspase-3 activation leading to apoptosis. Our findings give new insights into the underlying dysfunction of human dopaminergic neurons in PINK1 parkinsonism and sporadic PD, by utilising a truly representative in vitro cellular model of the disease.
###end p 12
###begin title 13
Materials and Methods
###end title 13
###begin p 14
All chemicals and reagents were obtained from Sigma or Invitrogen unless otherwise stated.
###end p 14
###begin title 15
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Generation of PINK1-deficient mice
###end title 15
###begin p 16
###xml 112 122 112 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s001">Methods S1</xref>
###xml 94 129 94 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">See supplementary <xref ref-type="supplementary-material" rid="pone.0002455.s001">Methods S1</xref> online</bold>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
The PINK1 deficient mice were generated by Lexicon Genetics Inc. (The Woodlands, Texas, USA). See supplementary Methods S1 online.
###end p 16
###begin title 17
Cell culture
###end title 17
###begin p 18
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Donato1">[39]</xref>
###xml 583 587 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Donato1">[39]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 88 93 <span type="species:ncbi:9606">human</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
###xml 440 445 <span type="species:ncbi:9606">human</span>
###xml 1473 1478 <span type="species:ncbi:9606">human</span>
###xml 1541 1546 <span type="species:ncbi:9606">human</span>
###xml 1572 1577 <span type="species:ncbi:9606">human</span>
Human NSCs (ReNcell VM NSCs) were provided by ReNeuron Ltd. Derivation of the line from human fetal ventral mesencephalon and maintenance has previously been described [39]. Briefly, NSCs were grown in laminin coated flasks/plates (Trevigen; 20 microg/ml in DMEM:F-12) in B27 medium (DMEM:F-12 with 1X B27 supplement, 2mM Glutamine, 10 Units/ml heparin and 50 mg/ml gentamycin) containing growth factors human bFGF [10ng/ml, Peprotech] and human EGF [20ng/ml, Peprotech]. Media on NSCs was changed every 48 hours. Differentiation was carried out using either the stdD or preD method [39]. For StdD differentiation, NSCs were seeded at 30,000 cells/cm on laminin and expanded to 80% confluency in B27 medium containing growth factors (+GFs). Differentiation was initiated by changing to Differentiation medium: B27 medium without growth factors or antibiotics and supplemented with 1mM dibutyrl-cAMP (Calbiochem) and 2ng/ml GDNF (Peprotech). Media was not changed for the first 5 days, then after that every 3-4 days. For the PreD method, NSCs were trypsinised and plated out at 30,000 cells/cm onto uncoated plates in B27 medium+GFs. NSCs were left to form aggregates for 7 days without a media change. Aggregates were then transferred to laminin-coated plates of equivalent surface area in B27 medium+GFs for 3-4 days to allow cells to disperse and reach 90% confluency. Differentiation was initiated and continued as for StdD protocol. ReNcell VM NSCs are referred to as human NSCs and ReNcell VM differentiated neurons are referred to as human midbrain neurons. SHSY5Y human neuroblastoma cells were maintained as described (Muqit et al 2006).
###end p 18
###begin p 19
###xml 284 294 284 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s001">Methods S1</xref>
###xml 731 741 725 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s001">Methods S1</xref>
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
For primary mouse cortical cultures, embryos were taken at gestational stage E16-E17. Animal husbandry and experimental procedures were performed in full compliance with the United Kingdom Animal (Scientific Procedures) Act of 1986. Cultures were set up as described in Supplementary Methods S1. Neurons were cultured in 96 well plates in maintenance medium [Neurobasal medium, 2% (v/v) B27 supplement, 2 mM glutamine, 100 I.U./ml penicillin and 100 I.U./ml streptomycin and 0.45% (v/v) D-(+) glucose]. Tissue harvested for biochemistry was snap frozen on dry ice and stored at -70degreesC. Embryos were obtained by crossing two heterozygote animals resulting in a mixture of F1 genotypes; genotyping is described in Supplementary Methods S1.
###end p 19
###begin title 20
Apoptosis and cell death/viability Assays
###end title 20
###begin title 21
Annexin V PE binding
###end title 21
###begin p 22
###xml 391 396 <span type="species:ncbi:9606">Human</span>
For analysis of apoptosis in NSCs and SHSY5Y cells, FACS was used to determine AnnexinV-FITC binding in conjunction with 7-Amino actiniomycin (7AAD) uptake according to manufacturer's instructions (BD Pharmingen). Briefly SHSY5Y cells were seeded at 600,000 cells per well of a 6 well plate, in triplicate, and incubated overnight in SHSY5Y medium containing DMSO or 60 nM STS (Calbiochem). Human NSCs were seeded in triplicate in 6 well plates at 200,000 per well. The following day NSCs were incubated in media containing DMSO only (1:1000) or STS (50 nM) for 3 h at 37degreesC prior to processing. A total of 10,000 cells were analysed for cell death by FACS Calibur (Beckton Dickenson, CA) with the Cell Quest software.
###end p 22
###begin title 23
Multiparameter Cytoxicity Assay
###end title 23
###begin p 24
###xml 167 172 <span type="species:ncbi:9606">human</span>
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
We used the Multiparameter Cytotoxicity 1 HCS Reagent kit (Cellomics) for the assessment of overall culture viability using multiple cell parameters in differentiated human and mouse neurons at different time points. The assay was carried out according to the manufacturer's instructions. Plates were analysed with an ArrayScan(c) HCS reader and Cytotoxicity Indices (CIs) calculated using the Multiparameter Cytotoxicity 1 BioApplication Software (Cellomics). A full explanation of this algorithm is provided on the supplier's website: . Briefly, nuclear size, morphology and cell density measurements are made on nuclei automatically identified in fluorescence channel 1. The BioApplication then measures nuclear intensity in channel 2 and the intensity of lysosomal stain in the cytoplasmic region in channel 3. Upper and lower thresholds are automatically set for nuclear morphology/size, cell membrane permeability and lysosomal mass from user-configurable reference wells (control or wild type neurons). The percentage (indices) of cells in each well that are outside of these thresholds is ascertained. The Cytotoxicity Index is the maximal of nuclear morphology index, membrane permeability index, lysosomal mass index and cell density index, for each well. A mean CI is calculated based on three replicate wells per clone/genotype.
###end p 24
###begin title 25
Counting apoptotic nuclei
###end title 25
###begin p 26
###xml 372 376 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Donato1">[39]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human neurons were differentiated using the Pre-D protocol on poly-L-lysine glass coverslips (Biocoat) pre-coated in laminin. At 5 and 43 days differentiation (dd), cultures were incubated with either 1 mM STS or vehicle (DMSO) for 3 h before being fixed. Immunostaining was undertaken using dual labeling with anti-betaIII tubulin, anti-TH and Hoechst 33342 as described [39]. Images were taken using an Axioplan Imaging microscope (Zeiss) using a 25X objective (see below). At least 50 adherent neurons per culture were examined and their nuclei scored as normal or pyknotic (fragmented/condensed) by a blinded observer. In addition, images from 5-10 non-overlapping fields of view were taken per culture using Axioplan software. Images were printed and the percentage of pyknotic versus normal neuronal nuclei were scored.
###end p 26
###begin title 27
Cytochrome C release
###end title 27
###begin p 28
Release of cytochrome c from mitochondria in SHSY5Y cells was carried out using the Apoptosis Detection Kit (MitoSciences) according to manufacturer's instructions.
###end p 28
###begin title 29
SDS-PAGE and immunoblot analysis
###end title 29
###begin p 30
###xml 30 40 30 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s001">Methods S1</xref>
###xml 16 47 16 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">supplementary <xref ref-type="supplementary-material" rid="pone.0002455.s001">Methods S1</xref> online</bold>
###xml 341 349 341 349 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S1</bold>
###xml 341 349 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s002"><bold>Table S1</bold></xref>
For details see supplementary Methods S1 online. Cells were lysed by the direct addition of sample buffer and protein lysates separated on 10% or 16% Tris-Glycine mini gels by SDS-PAGE, before transfer onto nitrocellulose membranes. Membranes were incubated in non-fat milk in PBS with 0.1% Tween-20 (PBST) then with primary antibodies (see Table S1). Membranes were washed then incubated with HRP-conjugated secondary antibodies (Dako). Membranes were incubated with SuperSignal West Pico Chemiluminescent Substrate (Pierce) and bands detected with x-ray films (BioMax). Equivalent protein loading was confirmed by stripping membranes and re-probing with anti-beta-actin antibody. Band densitometry was performed using Quantity One 4.6.6 software (BioRad).
###end p 30
###begin title 31
RNA extraction, cDNA synthesis and RT-PCR
###end title 31
###begin p 32
###xml 460 473 460 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-&#948;&#948;CT</sup>
###xml 481 485 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Livak1">[40]</xref>
###xml 305 310 <span type="species:ncbi:9606">Human</span>
Total RNA was isolated using TRIzol reagent and cDNA synthesised using random primers according to manufacturer's instructions. cDNA was diluted 1:5 in water prior to PCR. All TaqMan Real Time PCR reactions were performed using using FAM-labelled PINK1 probe and VIC/TAMRA-dye labelled Endogenous control Human RPLPO or GAPDH (Applied Biosystems). PCR was performed using the ABI PRISM 7700 Sequence Detection System. Gene expression was calculated using the 2-deltadeltaCT method [40].
###end p 32
###begin title 33
Synthesis and packaging of retroviral constructs
###end title 33
###begin p 34
###xml 324 334 322 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s001">Methods S1</xref>
###xml 547 554 545 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli.</italic>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 547 553 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
Optimal short hairpin RNA 19mer sequences targeted to human PINK1 (NM_032409) were determined using the Dharmacon siDESIGN Center (). The 19mers with the highest predicted efficacy (scores >/=7) were selected. Single stranded 64mers were obtained from Operon. The forward and reverse sequences are detailed in supplementary Methods S1 online. Oligomers were annealed and ligated into pSUPER.retro.puro (PSR) mammalian expression vector (Oligoengine) according to the manufacturer's protocol. Ligation mixtures were used to transform JS4 competent E.coli. Maxipreps of successfully ligated vectors were prepared using a Quaigen kit and sequenced. Vectors were packaged into retroviral particles using psi-NX-Ampho cells. Viral supernatant harvested from transfected cells was sterile filtered and stored at -70degreesC until required.
###end p 34
###begin title 35
Production of stable cell lines
###end title 35
###begin p 36
###xml 125 135 125 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s001">Methods S1</xref>
Early passage NSCs were infected with viral supernatant containing PSR vector, PSR containing shRNA sequences (supplementary Methods S1 online). When confluent, NSCs were split and transduced cells selected for using Puromycin (1 ug/ml). Cell colonies were picked and further propagated before screening by RT-PCR.
###end p 36
###begin title 37
Immunofluorescence and image acquisition
###end title 37
###begin p 38
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Donato1">[39]</xref>
###xml 164 172 164 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s002">Table S1</xref>
Immunostaining of coverslips and 96 well plates was carried out as described previously [39]. Details of all antibodies are available in supplementary data online (Table S1). For live dye staining of organelles, Mitotracker Red CMXRos or Lysotracker was used according to manufacturer's instructions. Coverslips were mounted onto slides using fluorescent mounting medium (Dakocytomation). Non-confocal images were obtained using an Axioplan 2 MOT microscope (Zeiss) with filters for FITC, Rhodamine and DAPI and Plan Neofluar 25x/0.8 Ph2 objective at RT. Images were taken using an AxioCam MRm (Zeiss) camera and controlled using the Axiovision Control software. Alternatively, images were obtained using an LSM510 META confocal microscopy system (Zeiss) equipped with "plan-Apochromat" 63x/1.40 Oil DIC objective at RT controlled by Zeiss LSM software. Fluorescence was recorded at 488nm using 30mW Ar-laser for excitation or at 543 nm using 1mW HeNE laser for excitation. Zeiss Immersol was used as imaging medium. For counting of tyrosine hydroxylase (TH) and neurofilament (NF) positive cells, the Cellomics ArrayScan(c) HCS reader was used and images from 30 fields of view per well were analysed using the Target Activation BioApplication software.
###end p 38
###begin title 39
Transmission Electron Microscopy
###end title 39
###begin p 40
###xml 230 231 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human NSCs were plated on 13mm Thermanox coverslips coated with laminin. When confluent, NSCs were differentiated using the SD/DA protocol for 47 dd and fixed using 3% glutaraldehyde in 0.1 M sodium cacodylate buffer and 5 mM CaCl2, pH 7.4. Specimens were dehydrated through a graded series of Analar Ethanol (70% 90% 100%). Cells were embedded in araldite resin mixture and sectioned using a Richert Ultracut S microtome. Sections were stained using 25% Uranyl acetate in methanol and Reynold's Lead Citrate and images were taken on a Philips CM10 transmission electron microscope at 3800X and 9800X magnification. Images were taken using the KeenView system from SIS, resized and annotated in Adobe Photoshop.
###end p 40
###begin title 41
Live cell imaging
###end title 41
###begin p 42
###xml 56 60 56 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Abramov1">[41]</xref>
###xml 80 90 80 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s001">Methods S1</xref>
###xml 66 98 66 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">supplementary <xref ref-type="supplementary-material" rid="pone.0002455.s001">Methods S1</xref> online.</bold>
###xml 212 213 212 213 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 222 223 222 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 225 226 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 234 235 234 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Live cell imaging was performed as described previously [41]. See supplementary Methods S1 online. Briefly, cells were bathed at RT in a HEPES-buffered salt solution (HBSS) containing (mM): 156 NaCl, 3 KCl, 2MgSO4, 1.25 KH2PO4, 2 CaCl2, 10 glucose and 10 HEPES, pH 7.35. For Deltapsim measurements, 25 nM TMRM was included and cells were incubated for 45 min. Z-stacks of >20 neurons per clone were obtained using a Zeiss LSM confocal microscope. Images were analysed using Lucida 6 software. For ROS measurements, MitoSOX (10 microM) was loaded for 10 min followed by washing. Dihydroethidium (HEt, 10 microM) was present in all solutions throughout the experiments. Confocal images were obtained using a Zeiss 510 uv-vis CLSM equipped with a META detection system and a 40x oil immersion objective. HEt or MitoSOX were excited using the 543 nm laser line and fluorescence measured using a 560nm longpass filter.
###end p 42
###begin p 43
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Measurement of total and reduced glutathione.</bold>
Measurement of total and reduced glutathione.
###end p 43
###begin p 44
###xml 18 28 18 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s001">Methods S1</xref>
###xml 4 35 4 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">supplementary <xref ref-type="supplementary-material" rid="pone.0002455.s001">Methods S1</xref> online</bold>
See supplementary Methods S1 online
###end p 44
###begin p 45
Citrate synthase activities
###end p 45
###begin title 46
Statistical analyses
###end title 46
###begin p 47
All experiments were performed with three different cell clones, in triplicate. Data were analysed by parametric Student T-tests and significance expressed as follows *P<0.05, **P<0.01, ***P<0.001 unless otherwise stated. For all graphs bars represent mean+/-SEM.
###end p 47
###begin title 48
Online supplementary material
###end title 48
###begin p 49
###xml 29 33 <span type="species:ncbi:10090">mice</span>
Generation of PINK1 knockout mice
###end p 49
###begin p 50
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Primary embryonic mouse cultures
###end p 50
###begin p 51
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s002">Table S1</xref>
Table S1 Antibodies
###end p 51
###begin p 52
SDS-PAGE and immunoblotting
###end p 52
###begin p 53
Production of stable cell lines
###end p 53
###begin p 54
Measurement of total and reduced glutathione
###end p 54
###begin p 55
Live cell imaging
###end p 55
###begin p 56
ETC activities
###end p 56
###begin title 57
Results
###end title 57
###begin title 58
###xml 51 56 <span type="species:ncbi:9606">human</span>
PINK1 is up-regulated following differentiation of human NSCs to dopaminergic neurons
###end title 58
###begin p 59
###xml 333 343 333 343 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1A</bold>
###xml 333 343 333 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s003"><bold>Figure S1A</bold></xref>
###xml 693 702 693 702 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 693 702 693 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g001"><bold>Figure 1A</bold></xref>
###xml 749 758 749 758 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 749 758 749 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g001"><bold>Figure 1C</bold></xref>
###xml 877 886 865 874 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 877 886 865 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g001"><bold>Figure 1C</bold></xref>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 318 323 <span type="species:ncbi:9606">human</span>
###xml 557 562 <span type="species:ncbi:9606">human</span>
###xml 737 742 <span type="species:ncbi:9606">human</span>
###xml 951 956 <span type="species:ncbi:9606">human</span>
###xml 1020 1025 <span type="species:ncbi:9606">human</span>
We first sought to validate the use of the human NSC model, differentiated to human midbrain neurons, as a useful model to test PINK1 function. RT-PCR confirmed upregulation of expression of a range of dopaminergic neuronal markers (tyrosine hydroxylase, TH, dopamine transporter, DAT) upon differentiation of NSCs to human neurons (Figure S1A). In addition there was an upregulation of the expression of markers Lmx1a and Nurr1, both of which are involved in committing precursor cells to dopaminergic differentiation. Furthermore we demonstrated that the human neurons expressing TH, also expressed PINK1. PINK1 expression is highest in mature neurons as demonstrated by immunofluorescence (Figure 1A). PINK1 was detected by RT-PCR in human NSCs (Figure 1C). Moreover, PINK1 expression was found to increase up to approximately100 fold following differentiation to neurons, (Figure 1C) suggesting a physiological role of PINK1 within differentiated human neurons. This high level of PINK1 expression in differentiated human DAergic neurons validated the use of this model in examining the effects of loss of PINK1 function.
###end p 59
###begin title 60
PINK1 Expression & Up-regulation.
###end title 60
###begin p 61
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 203 208 <span type="species:ncbi:9606">human</span>
###xml 633 638 <span type="species:ncbi:9606">human</span>
###xml 646 651 <span type="species:ncbi:9606">Human</span>
###xml 789 794 <span type="species:ncbi:9606">human</span>
###xml 1103 1108 <span type="species:ncbi:9606">human</span>
A) PINK1 expression in human dopaminergic neurons. Red; PINK1, green; TH, blue; hoescht. B) Western blot showing endogenous PINK1 protein expression in control (c) and PINK1 kd (with 90% mRNA knockdown) human neuronal lysates after 5 days differentiation. Anti-PINK1 (Novus) was used to detect PINK expression; beta-actin levels are shown as loading control. C) Histogram showing relative fold change in PINK1 mRNA expression levels between NSCs, 5 day differentiation (dd5), 30 day differentiation (dd30). PINK1 expression levels from pre-immortalised neural stem cells from 8 week old ventral mesencephalon (Midbrain P5) and adult human brain (Human Cb) are shown for comparison. Values represent mean of three replicate samples+/-s.e.m. D) Histogram showing expression of PINK1 mRNA in human neurons in four control (c1-4) and four PINK1 kd (kd1-4) selected clones relative to an endogenous control gene. RQs were normalised to that of c1; values represent mean of 3 replicate samples+/-standard error (s.e.m). E) Immunofluorescence images showing dopaminergic cells in control (i) and PINK1 kd (ii) human neuronal cultures after 5 days differentiation. Red; TH, green; betaIII tubulin, blue; Hoecsht.
###end p 61
###begin title 62
###xml 41 46 <span type="species:ncbi:9606">human</span>
RNAi-mediated knockdown of PINK1 mRNA in human cell lines
###end title 62
###begin p 63
###xml 314 325 314 325 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1 B</bold>
###xml 314 325 314 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s003"><bold>Figure S1 B</bold></xref>
###xml 871 880 868 877 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 871 880 868 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g001"><bold>Figure 1D</bold></xref>
###xml 1113 1122 1098 1107 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 1113 1122 1098 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g001"><bold>Figure 1B</bold></xref>
###xml 1258 1268 1243 1253 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1D</bold>
###xml 1258 1268 1243 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s003"><bold>Figure S1D</bold></xref>
###xml 301 306 <span type="species:ncbi:9606">human</span>
###xml 856 861 <span type="species:ncbi:9606">human</span>
###xml 1229 1234 <span type="species:ncbi:10090">mouse</span>
Using retroviral mediated PINK1 shRNA expression, levels of PINK1 knockdown ranging from 10-90% were achieved. The efficiency of PINK1 knockdown (PINK1 kd), determined by RT-PCR, was found to be shRNA sequence specific, with sequence #1029 resulting in >90% kd consistently in both the SHSY5Y and the human NSCs. (Figure S1 B). shRNA directed against a different gene (Lamin AC) did not reduce PINK1 mRNA levels (see S1B), confirming that this method did not result in non-specific PINK1 kd. Results shown are normalized for housekeeping gene, LRPO. However RT_PCR for other genes including two other control genes (beta-actin and GAPDH) as well as other PD genes (parkin and DJ-1) did not show significant alterations in expression between control and PINK1 kd (data not shown).. Knockdown of endogenous PINK1 mRNA was maintained after differentiation as human neurons (Figure 1D) even taking into account the approximately100 fold increase in PINK1 expression described above. Analysis of protein levels by Western blotting confirmed reduced levels of protein expression in #1029 clones compared with controls (Figure 1B). We similarly confirmed absence of PINK1 expression in cultured cortical neurons from the PINK1 knockout mouse model by Western blot (Figure S1D).
###end p 63
###begin title 64
###xml 46 51 <span type="species:ncbi:9606">human</span>
PINK1 is not necessary for differentiation of human neural stem cells to dopaminergic neurons
###end title 64
###begin p 65
###xml 224 233 224 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1E</bold>
###xml 224 233 224 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g001"><bold>Figure 1E</bold></xref>
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Donato1">[39]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 96 101 <span type="species:ncbi:9606">human</span>
###xml 828 833 <span type="species:ncbi:9606">human</span>
Human NSC lines, carrying the stable #1029 PINK1 kd shRNA, does not prevent differentation into human DAergic neurons as demonstrated by tyrosine hydroxylase (TH) immunostaining, following the PreD differentiation protocol (Figure 1E). No difference in TH expression was found between PINK1 kd neurons and controls using Western blot (data not shown). The PreD protocol generates the highest proportion of DAergic neurons in ReNcell cultures [39]. However, due to the formation of 'neuronal aggregates' in these cultures, accurate quantification of percentage TH+ neurons is extremely difficult using microscopy. In contrast, the StdD protocol gives rise to a monolayer of neurons, which permits the use of the Cellomics microscope and BioApplication software to robotically count (cytoplasmic) TH+ neurons. Control or PINK1 kd human neuronal cultures contained 1-5% TH+ neurons using the StdD protocol. There was no significant difference in the proportion of TH+ cells in control or PINK1 kd cells, either as a percentage of total cells or percentage of total neurons (data not shown).
###end p 65
###begin title 66
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
PINK1 deficiency results in age-related reduction in basal viability of human and mouse neurons
###end title 66
###begin p 67
###xml 702 712 702 712 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2B</bold>
###xml 702 712 702 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s004"><bold>Figure S2B</bold></xref>
###xml 1212 1221 1212 1221 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 1212 1221 1212 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g002"><bold>Figure 2A</bold></xref>
###xml 1221 1222 1221 1222 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 1329 1331 1317 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p&lt;</italic>
###xml 1649 1660 1637 1648 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C,D</bold>
###xml 1649 1660 1637 1648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g002"><bold>Figure 2C,D</bold></xref>
###xml 1824 1833 1812 1821 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2F</bold>
###xml 1824 1833 1812 1821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g002"><bold>Figure 2F</bold></xref>
###xml 1933 1942 1921 1930 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2E</bold>
###xml 1933 1942 1921 1930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g002"><bold>Figure 2E</bold></xref>
###xml 757 762 <span type="species:ncbi:9606">human</span>
We then investigated if PINK1 was necessary for the survival of neurons. Due to the characteristics of the different cell models, we employed different methods to assess viability and apoptosis. SHSY5Y cells are proliferative neuroblastoma cells that may be assessed using flow cytometry for both viability and apoptosis. Annexin V/PI flow cytometry of PINK1 kd SHSY5Y cells showed a significant reduction in the number of live cells after 96 h in culture when compared to control cells (p = 0.0263). Furthermore we observed a concomitant increase in cells undergoing early apoptosis, as shown by cells expressing annexin V only (p = 0.0023), and cells staining for both PI and annexin V (p = 0.0218) (Figure S2B). To assess the viability of differentiated human neurons, we employed a cytotoxicity assay for neurons at days 15, 30, 43 and 52 in culture. Cytotoxicity Indices (CI) for control and PINK kd cultures were calculated at each time point. There was no significant difference in basal viability at day 15, but from days 30 to 52, there was a significant and increasing difference in the mean CI of PINK1 kd neurons compared to controls, demonstrating an age-dependent effect of loss-of-PINK1 function (Figure 2A). By 52 days differentiation, the mean CI of PINK1 kd neurons was approximately30% above that of controls (p<0.001). Using the Cellomics software we examined differences in the various parameters quantified using the Multiparameter Cytotoxicity 1 BioApplication Software which are collated into the final CI readout. These revealed a striking reduction in mean nuclear size and fluorescence intensity, indicative of apoptosis (Figure 2C,D). Indeed we found a significant increase in the percentage apoptotic neurons in aged PINK1 kd cultures compared to controls by manual counting of pyknotic nuclei (Figure 2F). In addition there was a significant increase in mean lysosomal mass/pH in aged PINK1 kd neurons (Figure 2E).
###end p 67
###begin title 68
Long term viability is reduced in PINK1 deficient neurons.
###end title 68
###begin p 69
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 243 248 <span type="species:ncbi:10090">mouse</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 561 566 <span type="species:ncbi:9606">human</span>
###xml 903 908 <span type="species:ncbi:9606">human</span>
A) Graph showing an increase in mean CI over time of human PINK1 kd neurons compared to controls. Values shown are means+/-s.e.m of 3 control and 4 kd cultures, each measured in triplicate. B) Graph showing an increase in mean CI over time of mouse embryonic cortical neuronal cultures taken from wild type and PINK1 knockout mice. Values shown are means+/-s.e.m of wild type (PINK1+/+, n = 2), and homozygote (PINK1-/-, n = 3) cultures each measured in triplicate. C,D,E) Comparison of individual cell parameters assayed by the Cytotoxicity algorithm for aged human neurons (dd 52) with PINK1 kd compared to controls, including mean nuclear size, mean nuclear intensity, plasma membrane permeability and lysosomal mass/pH. Values shown are means+/-s.e.m of 3 control and 4 kd cultures, each measured in triplicate. F) Histogram showing percentage apoptotic neuronal nuclei in aged control and PINK1 kd human neurons under basal conditions. Values shown are mean percentages of neuronal nuclei that are pyknotic from 10 fields of view, +/-sem from 3 independent cultures.
###end p 69
###begin p 70
###xml 103 114 103 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2C)</bold>
###xml 103 114 103 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s004"><bold>Figure S2C)</bold></xref>
###xml 302 311 302 311 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 302 311 302 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g002"><bold>Figure 2B</bold></xref>
###xml 491 505 491 505 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2Di,ii</bold>
###xml 491 505 491 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002455.s004"><bold>Figure S2Di,ii</bold></xref>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 209 214 <span type="species:ncbi:10090">mouse</span>
We then sought to confirm these findings using primary embryonic cortical cultures from PINK1 KO mice (Figure S2C). Again we found the basal viability of neuronal cultures lacking PINK1 declined with age with mouse cortical KO neurons having significantly higher CI than controls by later time points (Figure 2B). Assessment of individual Multiparameter Cytotoxicity assay parameters at later time points (d30) revealed a decrease in nuclear intensity, and an increase in lysosomal mass/pH (Figure S2Di,ii) indicative of early cellular apoptosis.
###end p 70
###begin title 71
Lack of PINK1 sensitises neurons to mitochondrial-mediated apoptosis
###end title 71
###begin p 72
###xml 376 385 376 385 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 376 385 376 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g003"><bold>Figure 3A</bold></xref>
Using annexin V based flow cytometry we demonstrated that SHSY5Y cells exposed to 60nM staurosporine (STS) for 24hrs exhibited a significant reduction in the number of live cells in PINK1 kd clones compared to controls (p = 0.0002), as well as higher levels of early apoptosis in PINK1 kd cells (p<0.0001), and higher levels of total apoptosis in PINK1 kd cells (p = 0.0002) (Figure 3A). Preincubation of PINK1 kd cultures with 100 microM of the pan-caspase inhibitor Z-VAD-FMK 1hr prior to exposure with STS abolished cell death and markers of early and late apoptosis (data not shown).
###end p 72
###begin title 73
Apoptosis pathway in PINK1 kd SHSY5Y cells.
###end title 73
###begin p 74
A) Histogram showing a significant increase in apoptosis in PINK1 kd SHSY5Y cells in response to STS compared to controls. Cells were incubated with 60nM STS or vehicle overnight prior to analysis of annexinV/PI binding by FACS. Values represent mean of 20,000cells/well, of duplicate wells of 3 clones across 5 independent experiments+/-s.e.m. B) Panel a-h shows double immunofluorescence using Bax and Cox V antibodies in SHSY5Y cells treated with 0.75 microM STS. At 120 minutes, Bax (green) is seen in the cytoplasm and nucleus of control cells, with no overlap with a mitochondrial marker Cox V (red). In PINK1 kd cultures, arrows highlight two cells with evidence of nuclear condensation suggestive of apoptosis. In these cells, Bax immunofluorescence overlaps with Cox V immunofluorescence indicating Bax localisation in the mitochondria. Panel l-p shows double immunofluorescence using cytochrome c and Cox V antibodies. At 180 minutes, there is overlap of cytochrome c (green) and Cox V (red) in control cells indicating cytochrome c localisation in the mitochondria. However in PINK1 kd cells arrows indicate several apoptotic cells with diffuse cytosolic cytochrome c, indicating translocation from mitochondria to cytoplasm. Images are representative of two independent experiments with 3 clones. Images were acquired by obtaining z-stacks through cells at x63 oil objective. C) Western blot showing increased apoptosis on exposure to STS in PINK1 kd SHSY5Y cells. Cells were incubated with 0.75 microM microM STS for 6hrs. Cleaved caspase 9, cleaved caspase 3, and PARP expression is increased at earlier time points in PINK1 kd cells than in controls.
###end p 74
###begin p 75
###xml 853 862 849 858 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 853 862 849 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g003"><bold>Figure 3B</bold></xref>
###xml 863 866 859 862 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a&#8211;h</bold>
###xml 1546 1555 1542 1551 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 1546 1555 1542 1551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g003"><bold>Figure 3B</bold></xref>
###xml 1557 1560 1553 1556 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i&#8211;p</bold>
To assess the pathway of STS-induced apoptosis, and how it is sensitized in PINK1 kd cells, we used 0.75 microM STS for 4hrs, fixed cells at different intervals and performed double immunofluorescence to assess the localisation of Bax and cytochrome c. Under basal conditions Bax was observed in the cytosol and nucleus of cells, cells but not in the mitochondria (demonstrated by the failure of Bax to co-localise with the mitochondrial protein Cox V) whereas cytochrome c was localised to the mitochondria and showed overlap with Cox V staining. At 120 mins after addition of STS, some cells in the PINK1 kd cultures appeared apoptotic with nuclear fragmentation and condensation. In these cells, Bax staining co-localised with Cox V, suggesting translocation of Bax to the mitochondria from the cytosol in PINK1 kd cells undergoing apoptotic stress (Figure 3B,a-h). We further confirmed this finding using subcellular fractionation into mitochondrial and cytosolic fractions and immunoblotting for Bax (data not shown). After 180 mins of exposure to STS, we observed several cells per field in PINK1 kd cultures undergoing apoptosis as evidenced by nuclear fragmentation and condensation. In these cells Cox V staining demonstrated a loss of the tubular network of mitochondria, mitochondrial fragmentation and abnormal clustering. In addition to these nuclear and mitochondrial abnormalities, cytochrome c was distributed diffusely in the cytoplasm of these cells, confirming that it had been released from the mitochondria during apoptosis (Figure 3B, i-p).
###end p 75
###begin p 76
###xml 335 344 331 340 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C</bold>
###xml 335 344 331 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g003"><bold>Figure 3C</bold></xref>
To further confirm the induction of apoptosis in PINK1 kd cells, we assessed PINK1 kd cell lysates for active caspase-3 and PARP cleavage at 90 minute intervals following exposure to 0.75 microM STS. We demonstrate an increase in cleaved caspase 3, caspase 9, and an increase in cleaved PARP in PINK1 kd cultures compared to controls (Figure 3C). All these molecular events were activated at earlier time points in the PINK1 kd cells compared to controls suggesting an enhanced susceptibility to apoptosis via the mitochondrial pathway.
###end p 76
###begin p 77
###xml 346 354 346 354 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4</bold>
###xml 346 354 346 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g004"><bold>Figure 4</bold></xref>
###xml 354 360 354 360 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> A, B)</bold>
###xml 732 740 732 740 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4</bold>
###xml 732 740 732 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g004"><bold>Figure 4</bold></xref>
###xml 740 743 740 743 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> B)</bold>
###xml 92 97 <span type="species:ncbi:9606">human</span>
###xml 155 160 <span type="species:ncbi:9606">human</span>
We investigated whether a similar sensitivity to mitochondrial apoptosis was evident in the human neurons as well as the SHSY5Y cells. Both young and aged human PINK1 kd neurons demonstrated enhanced sensitivity to STS and a higher induction of mitochondrial apoptosis with increased expression of cleaved caspase 3, caspase 9, and cleaved PARP (Figure 4 A, B). The increased expression was confirmed using band densitometry. Of note, the immunoreactive bands obtained using lysates from d43 neurons are less intense than those of young neurons due to the reduced amount of material obtained from aged cultures. Interestingly, activated caspase-3 was also detected in lysate from PINK1 kd neurons treated with vehicle alone at d43 (Figure 4 B) suggesting an enhanced basal level of caspase-3-mediated apoptosis in the absence of PINK1 in aged neurons.
###end p 77
###begin title 78
###xml 22 27 <span type="species:ncbi:9606">human</span>
Apoptosis in PINK1 kd human neurons.
###end title 78
###begin p 79
###xml 223 228 <span type="species:ncbi:9606">human</span>
Western blots showing increase in basal (-) and STS-induced (+) cleaved caspase 3, cleaved caspase-9 (two bands approximately36 and approximately32 kDa) and cleaved PARP without PINK1 in young (A) (dd5) and aged (B) (dd43) human control and PINK1 kd neuronal cultures. Each lane is a sample from three pooled independent culture lysates. The lowest bands are immunoreactive degradation products which run at the foot of an SDS-PAGE gel.
###end p 79
###begin title 80
PINK1 deficiency in neurons leads to mitochondrial morphometric abnormalities
###end title 80
###begin p 81
###xml 258 267 256 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5A</bold>
###xml 258 267 256 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g005"><bold>Figure 5A</bold></xref>
###xml 787 796 785 794 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 787 796 785 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g005"><bold>Figure 5B</bold></xref>
###xml 958 967 956 965 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5D</bold>
###xml 958 967 956 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g005"><bold>Figure 5D</bold></xref>
###xml 1306 1314 1298 1306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1408 1417 1400 1409 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5C</bold>
###xml 1408 1417 1400 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g005"><bold>Figure 5C</bold></xref>
###xml 1595 1604 1587 1596 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5E</bold>
###xml 1595 1604 1587 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g005"><bold>Figure 5E</bold></xref>
###xml 2002 2013 1994 2005 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5F,G</bold>
###xml 2002 2013 1994 2005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g005"><bold>Figure 5F,G</bold></xref>
###xml 243 248 <span type="species:ncbi:9606">human</span>
###xml 544 549 <span type="species:ncbi:9606">human</span>
###xml 592 597 <span type="species:ncbi:10090">mouse</span>
###xml 619 624 <span type="species:ncbi:9606">human</span>
###xml 915 920 <span type="species:ncbi:9606">human</span>
###xml 1883 1888 <span type="species:ncbi:9606">human</span>
We investigated mitochondrial dysfunction in PINK1 kd cells using live cell imaging of TMRM fluorescence. We found that PINK1 deficiency leads to a reduction in mitochondrial membrane potential (psim) in both SHSY5Y cells (data not shown) and human neurons (Figure 5A). There was a mean reduction of 22% in the TMRM signal in PINK1 kd compared to controls (p = 0.046)(n = 60 neurons/culture taken from 3 individual clones). In addition, we found several lines of evidence suggesting increased mitochondrial proliferation in both young and aged human PINK1 kd neurons and in cortical PINK1 ko mouse neurons. First, with human PINK1 kd neurons, we found an increased uptake of the redox-sensitive dye, Mitotracker CMXROS, suggesting an increase in mitochondrial mass compared to controls (Figure 5B). Second, in PINK1 deficient neurons we found a marked up-regulation of mitochondrial OXPHOS complex subunits in aged human neurons as analysed by Western blot (Figure 5D). There was no significant percentage change in subunit expression between PINK1 kd and control neurons at dd5. However, by dd43, expression of complex I, III and V subunits had significantly increased in PINK1 kd neurons by 107.8+/-22.5 %, 125.1+/-5.4% and 233.8+/-17.9% respectively, as determined by band densitometry (p<0.01). Third, in vitro assays showed an increase in the mitochondrial citrate synthase activity within these cells (Figure 5C). We also found a significant increase in mitochondrial mass using direct quantification of mitochondria within individual neurons using transmission electron microscopy (TEM) (Figure 5E). However, no parallel increase in respiratory complex activity was detected using biochemical techniques in neuronal models (data not shown). Together these data suggest a compensatory increase in mitochondrial density in neurons lacking PINK-1. TEM analysis of young and aged human neurons lacking PINK1 also revealed an increase in the proportion of abnormal swollen mitochondria within cells (Figure 5F,G) further supporting the hypothesis that PINK1 functions to maintain mitochondrial integrity in neurons.
###end p 81
###begin title 82
Mitochondrial abnormalities in PINK1 deficient neurons.
###end title 82
###begin p 83
###xml 358 363 <span type="species:ncbi:9606">human</span>
###xml 624 629 <span type="species:ncbi:9606">human</span>
###xml 812 817 <span type="species:ncbi:9606">human</span>
###xml 1234 1239 <span type="species:ncbi:9606">human</span>
###xml 1447 1452 <span type="species:ncbi:9606">human</span>
###xml 1712 1717 <span type="species:ncbi:9606">human</span>
A) PINK deficiency leads to a reduced basal mitochondrial membrane potential (psim) in young PINK1 kd neurons compared to controls, analysed using TMRM fluorescence. Values are mean percentages of the control cultures (normalised to 100%) from three independent experiments. B) Histogram showing increased uptake of the redox sensitive dye MitotrackerRed in human PINK1 kd neuronal cultures compared to controls at early and later time points. Values represent means+/-sem of 3 control or three PINK1 kd cultures (measured in triplicate). C) Histogram showing increased citrate synthase (CS) activity in aged (d30) PINK1 kd human neurons compared to controls. Values represent means+/-sem from three independent cultures. D) Western blot showing expression of mitochondrial subunits in young (D5) and aged (D43) human neurons lacking PINK1 compared to controls. Note the increase in complex subunit expression in aged neurons lacking PINK1. Replicate lanes of pooled samples from three independent cultures are shown. Expression of OXPHOS subunits C-I-20 (ND6), C-II-30 (FeS), C-III-Core-2 and C-V-alpha is shown. beta-actin; loading control. E) Graph showing significantly increased mean number of mitochondria/cell in aged PINK1 kd human neurons compared to controls, as quantified by TEM analysis. Histogram shows mean number mitochondria per cell +/-sem averaged from at least 50 cells. F) Increased frequency of abnormal mitochondria of aged human PINK1 kd neurons compared to controls, quantified using TEM. Histogram shows mean frequency of abnormal mitochondria (per total number mitochondria in each cell) +/-sem, n = 50 cells. G) TEM images showing abnormal mitochondria (arrowheads) within aged (d47) human neurons lacking PINK1 (panel b, and at higher magnification in d) compared to control neurons (panel a). There are increased numbers of mitochondria within cells lacking PINK1 (panel b) compared to controls (panel A) and a higher proportion of mitochondria in PINK1 kd neurons appear swollen with disorganised christae (panels c, d). Scale bar in a,b; 10 microM, c  =  500 nM.
###end p 83
###begin title 84
PINK1 deficiency in neurons is associated with an increase in basal free radical production and decreased steady state levels of glutathione
###end title 84
###begin p 85
###xml 236 247 236 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g006">Figure 6A,B</xref>
###xml 530 532 528 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 533 534 531 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 831 839 823 831 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 831 839 823 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g006"><bold>Figure 6</bold></xref>
###xml 839 842 831 834 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C,D</bold>
###xml 1410 1421 1396 1407 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6A,B</bold>
###xml 1410 1421 1396 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g006"><bold>Figure 6A,B</bold></xref>
###xml 339 344 <span type="species:ncbi:9606">human</span>
We utilised live cell imaging techniques using the redox-sensitive dye dihydroethidium (HEt) which measures cytosolic ROS production and the mitochondrial targeted variant of this dye, Mitosox, to measure mitochondrial ROS production. (Figure 6A,B) The basal rate of ROS generation was significantly increased in the cytoplasm of PINK1 kd human neurons, showing a 2.79-fold increase in basal rate of fluorescence increase (mean = 279+/-11.3%, n = 189 cells, p<0.001). Stimulation of neurons with 50 mM KCl to transiently raise [Ca2+]c, increased the rate of ROS production in control cells, which showed a 3.2 fold increase in the rate of HEt fluorescence (from basal 100% to 321+/-19.3% while the response in PINK1 kd neurons was much smaller (from 279+/-11.3% to 300.1+/-14.7%, where 100%- basal rate of ROS in control neurons) (Figure 6C,D). We demonstrated a higher basal rate of mitochondrial superoxide production in PINK1 kd neurons compared to controls (the rate of increase of MitoSOX fluorescence was 2.1-fold higher in PINK1 kd neurons (mean = 212+/-14.1%, p<0.001). The complex I inhibitor, rotenone caused a smaller proportional increase in superoxide production in PINK1 kd (210.2% to 255.4+/-9.9%) compared to controls (100% to 212.1+/-11.6%) due to the higher basal levels of ROS generation, although the absolute rate of ROS generation in response to rotenone was higher in PINK1 kd neurons. (Figure 6A,B)
###end p 85
###begin title 86
Free Radical Production in PINK1 knockdown neurons.
###end title 86
###begin p 87
###xml 134 143 134 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g006">Figure 6A</xref>
###xml 985 990 <span type="species:ncbi:9606">human</span>
A) and (B) demonstrate a higher basal production of ROS production in mitochondria of PINK1 kd neurons compared to controls. Image in Figure 6A confirms mitochondrial localisation of Mitosox probe in neurons. Inhibition of complex 1 with rotenone induced a significant increase of ROS production in control cells. Inhibition of complex 1 in PINK1 kd cells slightly increased ROS production which is still higher than rotenone induced ROS production in control mitochondria. The basal rate of Mitosox fluorescence in control cells was taken as 100%. C) Shows an increase in the rate of HEt fluorescence in response to 50 mM KCL in control neurons. D) PINK1 kd neurons have higher basal rates of cytosolic ROS production compared to control neurons. Stimulation using KCl results in an increase in ROS production which is more marked in control than PINK1 kd neurons. E) Histogram showing decreased reduced and total glutathione concentrations in young (dd5 i) and in aged (dd43 ii) and human PINK1 kd neurons compared to controls. Values represent means +/-sem from triplicates of three independent samples.
###end p 87
###begin p 88
###xml 165 174 165 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6E</bold>
###xml 165 174 165 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g006"><bold>Figure 6E</bold></xref>
###xml 174 179 174 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i, ii</bold>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">total</italic>
###xml 149 154 <span type="species:ncbi:9606">human</span>
In addition to measuring ROS production we assayed the antioxidant defense mechanisms by analysing glutathione levels in young (dd5) and aged (dd43) human neurons. (Figure 6Ei, ii). We demonstrate a significant reduction in the total levels of glutathione (reduced+oxidised) in PINK1 kd cells, implying an impairment of glutathione synthesis. A decrease in the ratio of reduced:oxidised glutathione was not found.
###end p 88
###begin title 89
Aged midbrain derived neurons deficient in PINK1 contain lysosomal aggregates
###end title 89
###begin p 90
###xml 241 250 241 250 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7A</bold>
###xml 241 250 241 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g007"><bold>Figure 7A</bold></xref>
###xml 535 544 535 544 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 7B</bold>
###xml 535 544 535 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002455-g007"><bold>Figure 7B</bold></xref>
###xml 65 70 <span type="species:ncbi:9606">human</span>
In addition to morphological mitochondrial abnormalities in aged human PINK1 kd neurons, we also found large intracytoplasmic vesicular aggregates only in PINK1 kd neurons, reminiscent of autophagosomes, at a frequency of approximately 30% (Figure 7A). To determine whether these structures were lysosomal in origin, we applied the acidophilic Lysotracker dye to aged cultures and found this dye was taken up into these distinctive aggregates, which were considerably larger and more numerous in PINK1 kd neurons compared to controls (Figure 7B).
###end p 90
###begin title 91
Abnormal lysosomal morphology in PINK1 kd neurons.
###end title 91
###begin p 92
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 318 323 <span type="species:ncbi:9606">human</span>
A) TEM images of vesicular aggregates within surviving aged human neurons lacking PINK1 at dd47. A control neuron is shown in panel A. Panels b-d show aggregates in PINK1 kd neurons, panel c is an aggregate enlarged from b. Scale bars; a, b; 20 microM, d; 2 microM. B) Immunofluorescence images of aged (dd47) control human neurons (panels a-c) and PINK1 kd neurons (d-f) showing lysosomal morphology (red staining; panels b and e). Nuclei are shown in blue (panels a and d), merged images presented in panels c and f. Large and multiple aggregates seen only in PINK1 kd neurons are positive for the dye Lysotracker (panel d). ,Scale bar  =  20 microM
###end p 92
###begin p 93
###xml 97 104 97 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002455-t001">Table 1</xref>
The phenotypes observed in the different cell models of PINK1 loss-of-function are summarised in Table 1.
###end p 93
###begin title 94
Summary of the phenotypes observed with PINK1 deficiency in the different cell models used.
###end title 94
###begin p 95
N/A  =  not assessed
###end p 95
###begin title 96
Discussion
###end title 96
###begin p 97
###xml 791 795 791 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Donato1">[39]</xref>
###xml 1147 1155 1147 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 246 251 <span type="species:ncbi:9606">human</span>
###xml 285 290 <span type="species:ncbi:9606">human</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 507 512 <span type="species:ncbi:9606">Human</span>
###xml 553 558 <span type="species:ncbi:9606">human</span>
###xml 1034 1039 <span type="species:ncbi:9606">human</span>
###xml 1182 1187 <span type="species:ncbi:9606">human</span>
The aim of this study was to further elucidate the function of PINK1 in the prevention of DAergic degeneration seen in Parkinson's disease. We produced stable knockdown models of PINK1 using small interfering RNAs in two complementary cell lines-human neuroblastoma SHSY5Y and a novel human NSC line capable of high levels of DAergic differentiation. In addition, we used primary neuronal cultures from PINK1 knockout mice to corroborate our findings and control for potential non-specific effects of RNAi. Human neurons are generated from immortalised human fetal ventral mesencephalic neural stem cells (NSCs) which maintain a stable karyotype in culture, stable growth rates and readily differentiate into function neurons-thus providing advantages over commonly used "cancer" cell lines [39]. Differentiated NSCs cultures contain a high percentage of DAergic neurons which express typical neuronal markers and display characteristic action potentials. The use of stable RNAi allowed us to study the molecular changes occurring in human DAergic neurons during the process of ageing in a PINK1 null background. Our model therefore represents an in vitro system highly relevant to human PD, which is both progressive and age-dependent.
###end p 97
###begin title 98
PINK1 expression in dopaminergic neurons
###end title 98
###begin p 99
###xml 707 711 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Gandhi1">[21]</xref>
###xml 713 717 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Taymans1">[24]</xref>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:9606">human</span>
We found that PINK1 expression is up-regulated approximately100 fold during differentiation of human NSCs into human neurons, suggesting that PINK1 has an important function in differentiated neurons. However, it is important to note that PINK1 did not affect differentiation into the DAergic phenotype. This suggests PINK1 is not necessary for development which is in-line with the progression of the PINK1 mutation onset of PD. Endogenous PINK1 was expressed within soma and neurites of post-mitotic dopaminergic neurons, although it was not expressed exclusively in these subtypes. This is consistent with previous reports which show endogenous PINK1 expression in both neurons and glia throughout brain [21], [24]. PINK1 expression in neurons was highest within mature processes, where its expression may be most critical.
###end p 99
###begin title 100
PINK1 deficiency and long term survival
###end title 100
###begin p 101
###xml 193 201 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 280 290 280 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Park1">[32]</xref>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Yang1">[34]</xref>
###xml 419 432 419 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">age-dependent</italic>
###xml 649 657 649 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 73 78 <span type="species:ncbi:9606">human</span>
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
###xml 280 290 <span type="species:ncbi:7227">Drosophila</span>
A major finding in our study was the reduction in long term viability of human and mouse neurons deficient in PINK1. To our knowledge this is the first age-dependent phenotype reported for any in vitro cell model of PD. A progressive phenotype has been reported in PINK1 knockout Drosophila models, attributable to an increased level of apoptosis, but so far not in mammalian models [32], [34]. We observed significant age-dependent increases in cell death and apoptosis in mammalian neurons which provide a mechanism for the progressive phenotype seen in both sporadic and genetic forms of PD which have up until now been difficult to recapitulate in vitro.
###end p 101
###begin title 102
PINK1deficiency sensitises neurons to mitochondrial apoptosis
###end title 102
###begin p 103
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Petit1">[35]</xref>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Deng1">[37]</xref>
###xml 1212 1216 1212 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Petit1">[35]</xref>
###xml 1292 1296 1292 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Deng1">[37]</xref>
###xml 1298 1302 1298 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Haque1">[38]</xref>
###xml 1304 1308 1304 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-MacKeigan1">[42]</xref>
###xml 1310 1314 1310 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Pridgeon1">[43]</xref>
###xml 1851 1855 1851 1855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Haque1">[38]</xref>
###xml 2120 2124 2120 2124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Perier1">[44]</xref>
###xml 2126 2130 2126 2130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Perier2">[45]</xref>
###xml 144 152 <span type="species:ncbi:9606">patients</span>
###xml 318 323 <span type="species:ncbi:9606">human</span>
###xml 343 348 <span type="species:ncbi:10090">mouse</span>
###xml 1369 1374 <span type="species:ncbi:9606">human</span>
###xml 1594 1598 <span type="species:ncbi:10090">mice</span>
###xml 1809 1813 <span type="species:ncbi:10116">rats</span>
An increase in apoptosis has been previously reported in SHSY5Y cells following transient RNAi-mediated PINK1 kd, and in fibroblasts taken from patients with compound heterozygous PINK1 mutations [35], [37]. Interestingly, no basal increase in cell death and apoptosis was observed with PINK1 deficient differentiated human neurons or primary mouse neurons at early time points. However, molecular differences do exist between control and PINK1 kd cells at this early stage, specifically in their ability to handle mitochondrial stress. We find that PINK1 deficient cells are acutely sensitive to the toxin STS, which triggers mitochondrial apoptosis via opening of the mitochondrial permeability transition pore (MPTP) and subsequent cytochrome c release. In SHSY5Y cells lacking PINK1, Bax translocation to the mitochondria and cytochrome c release to the cytoplasm occurs earlier than in controls, and results in elevated levels of caspase activation (caspase-3 and caspase-9). In turn, increased levels of PARP cleavage and nuclear fragmentation are observed in PINK1 kd cells. Our findings are in line with previous reports demonstrating that PINK1 over-expression protects cells from STS-induced apoptosis [35] and transient RNAi-mediated PINK1 kd sensitises cells to various stressors [37], [38], [42], [43]. Our findings confirm the requirement of PINK1 within human neurons for the regulation of mitochondrial permeability transition, and prevention of caspase-3 mediated neuronal apoptosis. Our model shows some similarities to toxin based models of PD: the administration of MPTP to mice results in dopaminergic neuronal loss mediated by Bax translocation to the mitochondria, cytochrome c release, and activation of caspase 9 and caspase 3. In corroboration, over-expression of PINK1 in the SN of rats protects against the effects of MPTP [38]. In the MPTP model, the sensitivity to Bax-mediated apoptosis is determined by high levels of ROS (resulting from MPTP induced complex 1 deficiency) increasing the soluble pool of cytochrome c in the intermembrane space that may be released on stimulation by Bax. [44], [45] In our model, PINK1 deficiency is also associated with high levels of mitochondrial ROS production and thus the increased sensitivity to mitochondrial apoptosis may operate by a similar mechanism.
###end p 103
###begin title 104
PINK1 deficiency causes loss of mitochondrial membrane potential (psim)
###end title 104
###begin p 105
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-AbouSleiman1">[46]</xref>
###xml 483 487 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Valente2">[27]</xref>
###xml 489 493 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-AbouSleiman2">[47]</xref>
###xml 1110 1114 1106 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Park1">[32]</xref>
###xml 1116 1120 1112 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Yang1">[34]</xref>
###xml 1202 1209 1196 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 595 600 <span type="species:ncbi:9606">human</span>
Mitochondrial dysfunction is strongly implicated in the pathogenesis of PD, either as a cause or downstream hallmark of dopaminergic degeneration [46]. PINK1 is targeted to mitochondria where it is has been proposed to maintain mitochondrial membrane potential (psim), the driving force behind oxidative phosphorylation and ion transportation. Over-expression of wild type PINK1 in cell lines was found to protect cells from membrane depolarisation in response to proteasomal stress [27], [47]. Using live imaging techniques we show that PINK1 deficiency causes a reduction in the basal psim in human neurons, implicating a role for PINK1 in the maintenance of membrane potential, even in the absence of stress. This is a significant finding as mitochondrial potential is critical for the synthesis of ATP through the dissipation of the transmembrane proton gradient. ATP availability is critical for cellular anabolism and importantly for neurons, maintaining a resting plasma membrane potential for cell excitability. A reduced proton gradient would explain decreased ATP levels in PINK1 fly knockout models [32], [34] and it would be interesting to investigate whether this is due to a reduced psim in vivo.
###end p 105
###begin title 106
PINK1, ROS generation and glutathione levels
###end title 106
###begin p 107
###xml 187 191 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Bogaerts1">[11]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Hoepken1">[48]</xref>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Clark1">[31]</xref>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Wang1">[33]</xref>
###xml 864 868 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Goldberg1">[49]</xref>
###xml 869 873 869 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Yang2">[52]</xref>
###xml 432 440 <span type="species:ncbi:9606">patients</span>
###xml 480 488 <span type="species:ncbi:9606">patients</span>
###xml 641 646 <span type="species:ncbi:9606">human</span>
One important sequelae of mitochondrial dysfunction is increased generation of reactive oxygen species, which in turn can cause oxidative stress and damage to macromolecules within cells [11]. This damage extends to the mitochondrial respiratory components themselves, compromising function further. Evidence of oxidative stress and damage to proteins, lipids and nucleic acids has been found in the substantia nigra of sporadic PD patients and more recently, in fibroblasts from patients carrying PINK1 mutations [48]. We show here that in the absence of PINK1, ROS generation in both mitochondria and cytoplasm is increased, even in young human neurons. PINK1 knockout flies demonstrate increased sensitivity to oxidative stress [31], [33] and increased ROS generation and oxidative stress is similarly found in animal models of parkin and DJ-1 loss-of-function [49]-[52]. Hence ROS generation and elevated oxidative stress appears to be a unifying cellular phenotype in recessive Parkinsonism. This is the first demonstration that increased ROS production occurs early in a mammalian model of PD prior to neuronal stress and apoptosis, and hence suggests that it has an important role in the pathogenesis of neuronal dysfunction and death.
###end p 107
###begin p 108
###xml 282 290 280 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 290 294 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Pridgeon1">[43]</xref>
###xml 500 504 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Pridgeon1">[43]</xref>
###xml 506 510 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Hua1">[53]</xref>
PINK1 may exert its protective effect on psim and the prevention of ROS generation via phosphorylation of Tumor-necrosis factor associated protein-1 (TRAP1). TRAP1 (Hsp75) is an ATP-binding molecular chaperone co-localises with PINK1 in mitochondria, and is phosphorylated by PINK1 in vitro[43]. Silencing of TRAP1 in tumor cells also causes mitochondrial swelling, loss of psim, rapid increase in intracellular ROS generation and release of cytochrome C, identical to the effects of PINK1 knockdown [43], [53]. Rescue experiments placed TRAP1 downstream of PINK1, with phosphorylation of TRAP1 required for its protective activity, which indirectly prevents the release of cytochrome C and ROS generation in response to apoptogenic agents such as hydrogen peroxide. The role of a putative PINK1-TRAP1 interaction in dopaminergic neurons has yet to be investigated, but could provide a key to selective degeneration of these cells if heavily utilised as a protective pathway during stress.
###end p 108
###begin p 109
###xml 650 654 650 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Bharath1">[54]</xref>
###xml 724 732 724 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 807 811 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Chinta1">[55]</xref>
###xml 1028 1032 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Jain1">[56]</xref>
###xml 1331 1335 1331 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Greene1">[57]</xref>
###xml 1457 1461 1457 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Whitworth1">[58]</xref>
###xml 1670 1674 1670 1674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Park1">[32]</xref>
###xml 309 314 <span type="species:ncbi:9606">human</span>
###xml 457 465 <span type="species:ncbi:9606">patients</span>
###xml 1123 1128 <span type="species:ncbi:9606">human</span>
The primary mechanism for detoxification of ROS in the cytoplasm is the oxidation of reduced glutathione (GSH), which is regenerated harmlessly to the reduced species by the flavoenzyme glutathione reductase. We show that there is a significant decrease in steady state levels of total glutathione in primary human neurons lacking PINK1, which is likely to greatly impair their antioxidant defences. Evidence for decreased total GSH levels in the brains of patients with idiopathic PD has been widely reported and may occur as a result of decreased GSH synthesis, which is ATP dependent and thus compromised as a result of failing membrane potential [54]. Chronic inhibition of glutathione synthesis in dopaminergic neurons in vitro using buthionone-S-sulfoximime (BSO) reduced long term neuronal viability [55]. Numerous studies in rodents have demonstrated that glutathione deficiency by BSO administration results in mitochondrial swelling with vacuolization and rupture of the cristae and mitochondrial membranes seen by EM [56]. This may explain our observations of altered mitochondrial morphology in PINK1 deficient human neurons (see below). The importance of glutathione in recessive PD has already been explored: depleting parkin null flies of glutathione-S-transferase enzyme exacerbated the neurodegenerative phenotype [57]. Conversely, re-introduction of GST was found to rescue the mitochondrial swelling and neuronal loss in parkin knockouts [58]. Clearly, there exists a complex interrelationship between glutathione levels, respiratory chain impairment, mitochondrial morphology, and cell viability within neurons which both PINK1 and parkin co-operate [32].
###end p 109
###begin title 110
Altered mitochondrial integrity and proliferation
###end title 110
###begin p 111
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Clark1">[31]</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Park1">[32]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Yang1">[34]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Park1">[32]</xref>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Park1">[32]</xref>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Poole1">[59]</xref>
###xml 68 73 <span type="species:ncbi:9606">human</span>
Interestingly a disrupted mitochondrial morphology was seen in aged human neurons lacking PINK1. Neuronal mitochondria appeared enlarged, with disrupted cristae and greatly reduced matrix volume. This finding corroborates the striking muscle phenotype in PINK1 and parkin knockout fly models, where myofibrils contain vacuolated, swollen and dysmorphic mitochondria, with disorganised christae [31], [32], [34]. Enlarged mitochondria were also seen in surviving dopaminergic neurons, the frequency of which increased with age [32]. Using genetic complementation experiments PINK1 was subsequently shown to function 'up-stream' of parkin to regulate mitochondrial integrity [32]. Recently, it was found that loss-of-function of the mitochondrial fission-promoting component Drp1, caused lethality in PINK1 or parkin knockout flies [59]. Conversely, over-expression of Drp1 or mutations in mitochondrial fusion-promoting proteins (Mitofusin2 and OPA1) suppressed the PINK1 and parkin null phenotype. These experiments suggest that these PD genes co-operate to regulate mitochondrial dynamics and that mitochondrial fission (splitting) is stimulated in response to inactivation of the PINK1-parkin pathway.
###end p 111
###begin p 112
###xml 682 686 682 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Lee1">[60]</xref>
We provide interesting evidence for mitochondrial proliferation in PINK1 knockdown neurons, including increases in mean mitochondrial number per neuron, increased Mitotracker uptake, enhanced expression of respiratory chain complex subunits and elevated citrate synthase activity. Despite an increase in mass, no significant change in respiratory chain activity was detected in neurons lacking PINK1, implying that oxidative phosphorylation may be impaired in the increased numbers of mitochondria in these cells. It is established that increased levels of intracellular ROS may mediate changes in mitochondrial abundance and mtDNA copy number which occur during the ageing process [60]. The oxidative stress induced proliferation of mitochondria may initially be beneficial to compensate for dysfunctional mitochondria, and to supply ATP needed for cell survival. However increased numbers of mitochondria will also result in a further excess of ROS, which in the presence of insufficient antioxidant defense mechanisms, will produce more oxidative damage to cells. Increased oxidative damage will render neurons susceptible to death by apoptosis from mitochondrial membrane permeabilisation and cytochrome c release, or by necrosis due to insufficient ATP production. An increase in mitochondrial proliferation has so far not been reported in any other PD model.
###end p 112
###begin title 113
PINK1 deficiency and lysosomes
###end title 113
###begin p 114
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Petit1">[35]</xref>
###xml 674 678 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-MartinezVicente1">[61]</xref>
###xml 1344 1348 1340 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-ScherzShouval1">[62]</xref>
###xml 1475 1479 1468 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002455-Wei1">[63]</xref>
We also report here a novel phenotype in the surviving neurons of PINK1 deficient neurons which resembles the pathology observed in lysosomal storage diseases. Large intracellular bodies comprised of multivesicular 'aggregates' were detected in ageing PINK1 kd neurons, which were lysosomal in nature. PINK1 has not previously been implicated in lysosomal dysfunction but endogenous PINK1 expression has been detected in microsomes [35]. Lysosomes are present within autophagosomes, the multilamellar bodies responsible for proteolytic degradation of macromolecules and thought to be crucial in the clearance of amyloidogenic proteins such as alpha-synuclein and huntingtin [61]. Autophagy involves the non-selective degradation of proteins and organelles by lysosomes. However selective autophagy for certain damaged organelles such as mitochondria may occur in response to ROS. Moreover it has been proposed that mitochondria may act as a major source of the ROS signal required to activate autophagy. In our model of PINK1 deficiency we see an increase in autophagolysosomes suggesting an upregulation of autophagy. This may be occurring as a response to remove oxidatively damaged proteins and/or structurally abnormal mitochondria. The concurrent increase in cytosolic and mitochondrial ROS production may act as a signal for this process [62]. The lysosomal pathology we find in neurons resembles that seen in SHSY5Y cells over-expressing mutant beta-synuclein protein [63]. beta-synuclein is thought to be neuroprotective by interacting with and preventing the formation of alpha-synuclein inclusions. Pharmacological prevention of autophagy exacerbated cell death and alpha-synuclein toxicity, suggesting that they may fulfil a protective function in neurons. Enhancing formation of lysosomal clearance mechanisms in PD may therefore be a viable therapeutic strategy.
###end p 114
###begin p 115
###xml 100 105 <span type="species:ncbi:9606">human</span>
###xml 110 115 <span type="species:ncbi:10090">mouse</span>
In summary, to study the role of PINK1 in PD, we have generated models of PINK1 loss of function in human and mouse neurons. PINK1 is up-regulated during neuronal differentiation and plays a major role in the neuroprotection of mature neurons. Neurons that lack PINK1 function are prone to apoptosis via the intrinsic mitochondrial apoptosis pathway. Moreover loss of PINK1 function results in increased levels of oxidative stress and reduced mitochondrial membrane potential, suggesting that mitochondrial dysfunction directly leads to the increased susceptibility to apoptosis. Further characterisation of the molecular events within mitochondria that lack PINK1 will enable a better understanding of the pathophysiologic mechanisms that cause the phenotype of PINK1 loss-of-function. Persistent mitochondrial dysfunction over time ultimately results in structural changes of the mitochondria which are reminiscent of PINK1 knockout fly models, but to date have not been detected in mammalian models.
###end p 115
###begin p 116
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 151 156 <span type="species:ncbi:9606">human</span>
To our knowledge this is the first study to provide a functional role for PINK1 in human neurons, and specifically midbrain derived neurons. Modelling human neurodegenerative disease may only be successfully achieved through recapitulation of the ageing process. Under these circumstances we find an age-specific phenotype for loss of PINK1 function. This provides unique insights into the pathogenesis of sporadic PD in which the phenotype of oxidative stress, mitochondrial dysfunction and neuronal apoptosis has been well established. Further it suggests a convergence of the molecular pathways of PINK1-associated PD and sporadic PD.
###end p 116
###begin title 117
Supporting Information
###end title 117
###begin p 118
Supplementary Methods.
###end p 118
###begin p 119
(0.04 MB DOC)
###end p 119
###begin p 120
Click here for additional data file.
###end p 120
###begin p 121
(0.05 MB DOC)
###end p 121
###begin p 122
Click here for additional data file.
###end p 122
###begin p 123
###xml 992 997 <span type="species:ncbi:10090">mouse</span>
A) Graph showing the increase in mRNA of different markers of dopamine neurons following differentiation of NSCs to neurons, using the pre-D method. Expression of TH, DAT, lmx1a, and Nurr1 are significantly elevated upon differentiation. Levels are normalized to housekeeping gene ATPB5, and shown relative to fetal brain tissue expression. B) Graph showing the effects of four different shRNA constructs on PINK1 gene expression in SHSY5Y cells. Values are mean RQs of five clones+/-s.e.m. Construct 1; sequence 1029, Construct 2; sequence 2194. Construct 3; 780, Construct 4; lamin AC. C) Graph showing knockdown effect of shRNA construct 1 (1029) on PINK1 gene expression in individual NSC clones normalized to expression levels with vector only. Values are mean RQ; plus and minus error bars represent maximum and minimum possible RQ value. D) Western blot showing endogenous PINK1 expression in primary cortical neurons in either wild type (WT), Heterozygote (Ht) or PINK1 knockout (KO) mouse primary cortical neurons. Anti-PINK1 (Novus) was used to detect PINK expression; beta-actin levels are shown as loading control.
###end p 123
###begin p 124
(0.89 MB TIF)
###end p 124
###begin p 125
Click here for additional data file.
###end p 125
###begin p 126
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 703 708 <span type="species:ncbi:10090">mouse</span>
###xml 903 908 <span type="species:ncbi:10090">mouse</span>
A) Histogram showing no significant increase in basal levels of apoptosis in PINK1 kd human NSCs compared to control cells after 24 h in culture. Levels of AnnexinV/PI staining were quantified using FACS. Values represent means of 3 independent experiments measured in triplicate+/-sem. B) Histogram demonstrating significant differences in live cell number, early apoptosis (annexin V only) and total apoptosis (annexin V+PI) in PINK1 kd SHSY5Y cells compared to controls. Cells were cultured for 96 hours before assaying using annexin V based FACS. Values represent mean values of 3 clones plated in duplicate and 20,000 cells measured per well+/-sem C) Double immunofluorescnece of primary embryonic mouse neuronal cultures using MAP2 (green), GFAP (red) and Hoechst (blue). Scale bar  =  20 microM. D) Comparison of individual cell parameters assayed by the Cytotoxicity algorithm for aged PINK1 KO mouse cortical neurons (day 30) compared to wild type controls, including mean nuclear size, mean nuclear intensity and lysosomal mass/pH. Values shown are means+/-s.e.m of 2 wild type and 3 KO cultures, each measured in triplicate.
###end p 126
###begin p 127
(4.00 MB TIF)
###end p 127
###begin p 128
Click here for additional data file.
###end p 128
###begin p 129
We thank Kerrie Venner for technical help and assistance. We are also grateful to the Neurogenetics Service staff for their support. We thank Priyadarshini Pande for contribution to data. AWK wrote the manuscript.
###end p 129
###begin title 130
References
###end title 130
###begin article-title 131
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.
###end article-title 131
###begin article-title 132
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
###end article-title 132
###begin article-title 133
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.
###end article-title 133
###begin article-title 134
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.
###end article-title 134
###begin article-title 135
Hereditary early-onset Parkinson's disease caused by mutations in PINK1.
###end article-title 135
###begin article-title 136
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease.
###end article-title 136
###begin article-title 137
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
###end article-title 137
###begin article-title 138
Understanding the molecular causes of Parkinson's disease.
###end article-title 138
###begin article-title 139
###xml 24 30 <span type="species:ncbi:9606">humans</span>
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
###end article-title 139
###begin article-title 140
Mechanism of toxicity in rotenone models of Parkinson's disease.
###end article-title 140
###begin article-title 141
Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria?
###end article-title 141
###begin article-title 142
Oxidative stress in Parkinson's disease.
###end article-title 142
###begin article-title 143
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.
###end article-title 143
###begin article-title 144
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization.
###end article-title 144
###begin article-title 145
Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death.
###end article-title 145
###begin article-title 146
###xml 36 51 <span type="species:ncbi:10090">transgenic mice</span>
Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.
###end article-title 146
###begin article-title 147
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.
###end article-title 147
###begin article-title 148
Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability.
###end article-title 148
###begin article-title 149
Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.
###end article-title 149
###begin article-title 150
C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.
###end article-title 150
###begin article-title 151
###xml 24 29 <span type="species:ncbi:9606">human</span>
PINK1 protein in normal human brain and Parkinson's disease.
###end article-title 151
###begin article-title 152
Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress.
###end article-title 152
###begin article-title 153
Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
###end article-title 153
###begin article-title 154
###xml 35 38 <span type="species:ncbi:10116">rat</span>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
Distribution of PINK1 and LRRK2 in rat and mouse brain.
###end article-title 154
###begin article-title 155
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa.
###end article-title 155
###begin article-title 156
Pathogenic mutations in Parkinson disease.
###end article-title 156
###begin article-title 157
PINK1 mutations are associated with sporadic early-onset parkinsonism.
###end article-title 157
###begin article-title 158
Biological effects of the PINK1 c.1366C>T mutation: implications in Parkinson disease pathogenesis.
###end article-title 158
###begin article-title 159
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.
###end article-title 159
###begin article-title 160
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Silencing of the Pink1 gene expression by conditional RNAi does not induce dopaminergic neuron death in mice.
###end article-title 160
###begin article-title 161
###xml 0 10 <span type="species:ncbi:7227">Drosophila</span>
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
###end article-title 161
###begin article-title 162
###xml 29 39 <span type="species:ncbi:7227">Drosophila</span>
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.
###end article-title 162
###begin article-title 163
###xml 61 71 <span type="species:ncbi:7227">Drosophila</span>
Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila.
###end article-title 163
###begin article-title 164
###xml 98 108 <span type="species:ncbi:7227">Drosophila</span>
Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.
###end article-title 164
###begin article-title 165
Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations.
###end article-title 165
###begin article-title 166
PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c.
###end article-title 166
###begin article-title 167
Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y.
###end article-title 167
###begin article-title 168
Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP.
###end article-title 168
###begin article-title 169
###xml 73 78 <span type="species:ncbi:9606">human</span>
Differential development of neuronal physiological responsiveness in two human neural stem cell lines.
###end article-title 169
###begin article-title 170
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
###end article-title 170
###begin article-title 171
Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation.
###end article-title 171
###begin article-title 172
###xml 26 31 <span type="species:ncbi:9606">human</span>
Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance.
###end article-title 172
###begin article-title 173
PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1.
###end article-title 173
###begin article-title 174
Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.
###end article-title 174
###begin article-title 175
Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease.
###end article-title 175
###begin article-title 176
Expanding insights of mitochondrial dysfunction in Parkinson's disease.
###end article-title 176
###begin article-title 177
A heterozygous effect for PINK1 mutations in Parkinson's disease?
###end article-title 177
###begin article-title 178
Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.
###end article-title 178
###begin article-title 179
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.
###end article-title 179
###begin article-title 180
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Mitochondrial dysfunction and oxidative damage in parkin-deficient mice.
###end article-title 180
###begin article-title 181
###xml 0 10 <span type="species:ncbi:7227">Drosophila</span>
Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress.
###end article-title 181
###begin article-title 182
###xml 16 26 <span type="species:ncbi:7227">Drosophila</span>
Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.
###end article-title 182
###begin article-title 183
Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis.
###end article-title 183
###begin article-title 184
Glutathione, iron and Parkinson's disease.
###end article-title 184
###begin article-title 185
Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
###end article-title 185
###begin article-title 186
Glutathione deficiency leads to mitochondrial damage in brain.
###end article-title 186
###begin article-title 187
###xml 31 41 <span type="species:ncbi:7227">Drosophila</span>
Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis.
###end article-title 187
###begin article-title 188
###xml 83 93 <span type="species:ncbi:7227">Drosophila</span>
Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease.
###end article-title 188
###begin article-title 189
The PINK1/Parkin pathway regulates mitochondrial morphology.
###end article-title 189
###begin article-title 190
Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress.
###end article-title 190
###begin article-title 191
Autophagy and neurodegeneration: when the cleaning crew goes on strike.
###end article-title 191
###begin article-title 192
ROS, mitochondria and the regulation of autophagy.
###end article-title 192
###begin article-title 193
Enhanced lysosomal pathology caused by beta -synuclein mutants linked to dementia with lewy bodies.
###end article-title 193
###begin p 194
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 194
###begin p 195
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: MRC UK program grant, Wellcome Trust research Training Fellowship
###end p 195

